Woodstock Corp Fibrogen Inc Transaction History

Woodstock Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 07, 2022	SELL	$9.93 - $15.39 $172,831 - $267,862	-17,405 Closed	0 $0
Q3 2021 Oct 05, 2021	SELL	$10.18 - $26.64 $128,817 - $337,102	-12,654 Reduced 42.1%	17,405 $178,000
Q1 2020 Apr 03, 2020	BUY	$23.3 - $45.96 $187,308 - $369,472	8,039 Added 36.51%	30,059 $1.05 Million
Q4 2019 Jan 13, 2020	BUY	$34.58 - $48.06 $414,960 - $576,720	12,000 Added 119.76%	22,020 $944,000
Q3 2019 Oct 02, 2019	SELL	$36.98 - $48.45 $313,220 - $410,371	-8,470 Reduced 45.81%	10,020 $371,000
Q3 2018 Oct 03, 2018	SELL	$56.3 - $67.25 $558,777 - $667,456	-9,925 Reduced 34.93%	18,490 $1.12 Million
Q3 2017 Oct 06, 2017	BUY	$33.4 - $53.9 $949,061 - $1.53 Million	28,415	28,415 $1.53 Million

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Woodstock Corp, based on Form 13F filings with the SEC.

Stay updated on Woodstock Corp with notifications on news.